查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1876804

高階傷口護理市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Advanced Wound Care Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球高級傷口護理市場價值為 156 億美元，預計到 2034 年將以 5.9% 的複合年成長率成長至 275 億美元。

先進傷口護理市場 - IMG1

市場成長的促進因素包括全球老年人口的不斷擴大、慢性病盛行率的上升、已開發地區傷口護理技術的進步以及外科手術數量的增加。美國仍然是主要貢獻者，這反映出其急診手術和擇期手術的數量都很高。從創傷相關病例到美容手術，手術量的成長顯著提高了對先進傷口護理解決方案的需求。這些技術在現代醫療保健中日益重要，有助於加速患者康復、最大限度地減少術後併發症並改善患者預後。隨著醫療保健系統越來越重視縮短住院時間和提高效率，先進的傷口護理解決方案正成為術後治療路徑和慢性傷口管理的重要組成部分。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 156億美元
預測值 275億美元
複合年成長率 5.9%

慢性疾病發生率的不斷上升進一步推動了市場需求。糖尿病、心血管疾病和肥胖等疾病常常導致傷口癒合緩慢，需要專門的介入措施。與傳統敷料相比，包括水膠體和藻酸鹽在內的先進傷口護理產品更受歡迎，因為它們能夠最佳化傷口管理，維持濕潤環境，降低感染風險，並加速癒合。醫院和診所正在逐步採用這些解決方案，以確保患者更快康復並獲得更好的治療效果，從而推動市場向前發展。

2024年，先進傷口敷料市佔率達74.5%。與傳統紗布不同，這些敷料融合了水膠體、泡棉、藻酸鹽和抗菌層等創新技術。它們經過專門設計，旨在維持最佳傷口環境，促進癒合，並預防感染，因此在慢性傷口、手術切口和燒傷的治療中不可或缺。

美國高級傷口護理市場預計在2024年達到50億美元。這一成長主要受慢性傷口（尤其是糖尿病相關傷口）盛行率上升的推動。糖尿病足潰瘍和其他癒合緩慢的傷口通常需要先進的解決方案，包括專用敷料和負壓傷口治療（NPWT），這促進了美國市場的持續擴張。

全球高級傷口照護市場的主要參與者包括：Integra LifeSciences Corporation、Medela AG、Smith and Nephew、B. Braun、WoundEL Health Care、Coloplast、Molnlycke Health Care、Talley Group Ltd、Hollister Incorporated、3M、Medline Industries、Organogenesis、HARTMANN International、Accel-H Technologies Technologiesal. Rauscher 和 Sky Medical Technology。這些公司採用多種策略來鞏固其市場地位。他們專注於持續的產品創新，開發新一代敷料、負壓傷口治療系統和生物製劑，以應對複雜的傷口。與醫院、診所和研究機構建立策略合作夥伴關係，可以擴大其分銷網路並提升信譽。向新興市場進行地理擴張，使公司能夠滿足不斷成長的需求，而併購則有助於整合資源和技術組合。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
  • 產業影響因素
    • 成長促進因素
      • 全球老年人口不斷增加
      • 慢性病發生率不斷上升
      • 已開發地區傷口護理產業的技術進步
      • 外科手術數量不斷增加
    • 產業陷阱與挑戰
      • 先進設備的高成本
      • 缺乏熟練的醫療保健專業人員
    • 市場機遇
    • 智慧傷口護理技術的發展
    • 客製化和患者專屬解決方案
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 亞太地區
    • 歐洲
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL 分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀錶板
  • 關鍵進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章：市場估算與預測：依產品分類，2021-2034年

  • 主要趨勢
  • 進階傷口敷料
    • 泡棉敷料
    • 水膠體敷料
    • 薄膜敷料
    • 海藻酸鹽敷料
    • 水凝膠敷料
    • 膠原蛋白敷料
    • 其他高級敷料
  • 傷口治療設備
    • 負壓傷口治療
    • 氧氣和高壓氧設備
    • 電刺激裝置
    • 壓力釋放裝置
    • 其他傷口治療設備
  • 傷口護理生物製劑
    • 皮膚替代品
      • 生物
        • 同種異體移植
        • 異種移植
        • 其他生物製劑
      • 合成的
    • 局部用藥

第6章：市場估算與預測：依應用領域分類，2021-2034年

  • 主要趨勢
  • 慢性的
    • 糖尿病潰瘍
    • 壓瘡
    • 靜脈性腿部潰瘍
    • 其他慢性應用
  • 急性
    • 手術傷口
    • 創傷性傷口
    • 燒傷

第7章：市場估算與預測：依最終用途分類，2021-2034年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 家庭護理機構
  • 其他最終用途

第8章：市場估算與預測：依地區分類，2021-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • 3M
  • Accel-Heal Technologies
  • B. Braun
  • Cardinal Health
  • Coloplast
  • ConvaTec Group
  • DeRoyal Industries, Inc.
  • HARTMANN International
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Lohmann & Rauscher
  • Medela AG
  • Medline Industries
  • Molnlycke Health Care
  • Organogenesis
  • Sky Medical Technology
  • Smith and Nephew
  • Talley Group Ltd
  • Vomaris Innovations
  • WoundEL Health Care
簡介目錄
Product Code: 2871

The Global Advanced Wound Care Market was valued at USD 15.6 billion in 2024 and is estimated to grow at a CAGR of 5.9% to reach USD 27.5 billion by 2034.

Advanced Wound Care Market - IMG1

Market growth is driven by the expanding geriatric population worldwide, the rising prevalence of chronic diseases, advancements in wound care technologies in developed regions, and increasing surgical procedures. The U.S. remains a leading contributor, reflecting high numbers of both emergency and elective surgeries. The rise in surgical volumes, from trauma-related cases to aesthetic procedures, has significantly heightened the demand for advanced wound care solutions. These technologies are increasingly critical in modern healthcare, facilitating faster recovery, minimizing post-surgical complications, and enhancing patient outcomes. With healthcare systems emphasizing reduced hospital stays and improved efficiency, advanced wound care solutions are emerging as essential components of post-surgical treatment pathways and chronic wound management.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$15.6 billion
Forecast Value$27.5 billion
CAGR5.9%

The increasing incidence of chronic diseases further fuels market demand. Conditions such as diabetes, cardiovascular disorders, and obesity often result in wounds that are slow to heal and require specialized interventions. Advanced wound care products, including hydrocolloids and alginates, are preferred over traditional dressings because they provide optimized wound management, maintain a moist environment, reduce infection risk, and accelerate healing. Hospitals and clinics are progressively adopting these solutions to ensure quicker recovery and better patient outcomes, driving the market forward.

The advanced wound dressings segment held a 74.5% share in 2024. Unlike conventional gauze, these dressings integrate innovative technologies such as hydrocolloids, foams, alginates, and antimicrobial layers. They are specifically designed to maintain optimal wound conditions, enhance healing, and prevent infections, making them indispensable in the management of chronic wounds, surgical incisions, and burns.

U.S. Advanced Wound Care Market reached USD 5 billion in 2024. The growth is primarily fueled by the increasing prevalence of chronic wounds, particularly those associated with diabetes. Diabetic foot ulcers and other slow-healing wounds often require advanced solutions, including specialized dressings and negative pressure wound therapy (NPWT), contributing to sustained market expansion in the country.

Key players in the Global Advanced Wound Care Market include Integra LifeSciences Corporation, Medela AG, Smith and Nephew, B. Braun, WoundEL Health Care, Coloplast, Molnlycke Health Care, Talley Group Ltd, Hollister Incorporated, 3M, Medline Industries, Organogenesis, HARTMANN International, Accel-Heal Technologies, Cardinal Health, DeRoyal Industries, Inc., ConvaTec Group, Lohmann & Rauscher, and Sky Medical Technology. Companies in the Global Advanced Wound Care Market employ a variety of strategies to strengthen their market foothold. They focus on continuous product innovation by developing next-generation dressings, NPWT systems, and biologics to address complex wounds. Strategic partnerships with hospitals, clinics, and research institutions expand their distribution networks and enhance credibility. Geographic expansion into emerging markets allows companies to tap into growing demand, while mergers and acquisitions consolidate resources and technology portfolios.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Production trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing geriatric population worldwide
      • 3.2.1.2 Increasing incidence of chronic diseases
      • 3.2.1.3 Technological advancement in wound care industry in developed region
      • 3.2.1.4 Increasing number of surgical procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High Cost of Advanced Devices
      • 3.2.2.2 Lack of skilled healthcare Professionals
    • 3.2.3 Market opportunities
    • 3.2.4 Development of smart wound care technologies
    • 3.2.5 Customized and patient-specific solutions
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Asia Pacific
    • 3.4.3 Europe
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers and acquisitions
    • 4.7.2 Partnerships and collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Advanced wound dressing
    • 5.2.1 Foam dressings
    • 5.2.2 Hydrocolloid dressings
    • 5.2.3 Film dressings
    • 5.2.4 Alginate dressings
    • 5.2.5 Hydrogel dressings
    • 5.2.6 Collagen dressings
    • 5.2.7 Other advanced dressings
  • 5.3 Wound therapy devices
    • 5.3.1 Negative pressure wound therapy
    • 5.3.2 Oxygen and hyperbaric oxygen equipment
    • 5.3.3 Electric stimulation devices
    • 5.3.4 Pressure relief devices
    • 5.3.5 Other wound therapy devices
  • 5.4 Wound care biologics
    • 5.4.1 Skin Substitutes
      • 5.4.1.1 Biological
        • 5.4.1.1.1 Allograft
        • 5.4.1.1.2 Xenograft
        • 5.4.1.1.3 Other biologicals
      • 5.4.1.2 Synthetic
    • 5.4.2 Topical Agents

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Chronic
    • 6.2.1 Diabetic ulcer
    • 6.2.2 Pressure ulcer
    • 6.2.3 Venous legs ulcer
    • 6.2.4 Other chronic applications
  • 6.3 Acute
    • 6.3.1 Surgical Wounds
    • 6.3.2 Traumatic wounds
    • 6.3.3 Burns

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Specialty clinics
  • 7.4 Home care settings
  • 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 1.1.1 U.S.
    • 1.1.2 Canada
  • 8.3 Europe
    • 1.1.3 Germany
    • 1.1.4 UK
    • 1.1.5 France
    • 1.1.6 Spain
    • 1.1.7 Italy
    • 1.1.8 Netherlands
  • 8.4 Asia Pacific
    • 1.1.9 China
    • 1.1.10 Japan
    • 1.1.11 India
    • 1.1.12 Australia
    • 1.1.13 South Korea
  • 8.5 Latin America
    • 1.1.14 Brazil
    • 1.1.15 Mexico
    • 1.1.16 Argentina
  • 8.6 Middle East and Africa
    • 1.1.17 South Africa
    • 1.1.18 Saudi Arabia
    • 1.1.19 UAE

Chapter 9 Company Profiles

  • 9.1 3M
  • 9.2 Accel-Heal Technologies
  • 9.3 B. Braun
  • 9.4 Cardinal Health
  • 9.5 Coloplast
  • 9.6 ConvaTec Group
  • 9.7 DeRoyal Industries, Inc.
  • 9.8 HARTMANN International
  • 9.9 Hollister Incorporated
  • 9.10 Integra LifeSciences Corporation
  • 9.11 Lohmann & Rauscher
  • 9.12 Medela AG
  • 9.13 Medline Industries
  • 9.14 Molnlycke Health Care
  • 9.15 Organogenesis
  • 9.16 Sky Medical Technology
  • 9.17 Smith and Nephew
  • 9.18 Talley Group Ltd
  • 9.19 Vomaris Innovations
  • 9.20 WoundEL Health Care